Compared to Aluminum Hydroxide Adjuvant, Montanide ISA 206 VG Induces a Higher and More Durable Neutralizing Antibody Response against FMDV in Goats

References
1. Grubman MJ, Baxt B. Foot-and-mouth disease. Clinical
microbiology reviews. 2004;17(2):465-93.
2. Khorasani A, Madadgar O, Soleimanjahi H, Keyvanfar
H, Mahravani H. Evaluation of the efficacy of a new
oil-based adjuvant ISA 61 VG FMD vaccine as a
potential vaccine for cattle. Iranian journal of veterinary
research. 2016;17(1):8.
3. Gadir M, Azimi S, Harzandi N, Hemati B,
Eskandarzade N. Molecular detection, genetic diversity,
and phylogenetic analysis of foot-and-mouth disease
virus (FMDV) type O in Iran during 2015-2016. Iranian
Journal of Veterinary Research. 2023;24(1):30-6.
4. Niedbalski W, Fitzner A, Bulenger K. Recent progress
in vaccines against foot-and-mouth disease. Medycyna
Weterynaryjna. 2019;75(2):1-6.
5. Park S, Kim JY, Ryu K-H, Kim A-Y, Kim J, Ko Y-J, et
al. Production of a foot-and-mouth disease vaccine
antigen using suspension-adapted BHK-21 cells in a
bioreactor. Vaccines. 2021;9(5):505.
6. Kumar A, Sharma A, Tirpude NV, Padwad Y, Hallan V,
Kumar S. Plant-derived immuno-adjuvants in vaccines
formulation: A promising avenue for improving
vaccines efficacy against SARS-CoV-2 virus.
Pharmacological Reports. 2022;74(6):1238-54.
7. Park M-E, Lee S-Y, Kim R-H, Ko M-K, Lee K-N, Kim
S-M, et al. Enhanced immune responses of foot-andmouth disease vaccine using new oil/gel adjuvant
mixtures in pigs and goats. Vaccine. 2014;32(40):5221-7.
8. Cao Y. Adjuvants for foot-and-mouth disease virus
vaccines: recent progress. Expert review of vaccines.
2014;13(11):1377-85.
9. Oleszycka E, McCluskey S, Sharp FA, Muñoz‐Wolf N,
Hams E, Gorman AL, et al. The vaccine adjuvant alum
promotes IL‐10 production that suppresses Th1
responses. European journal of immunology.
2018;48(4):705-15.
10. Hoare R, Jung S-J, Ngo TP, Bartie K, Bailey J,
Thompson KD, et al. Efficacy and safety of a nonmineral oil adjuvanted injectable vaccine for the
protection of Atlantic salmon (Salmo salar L.) against
Flavobacterium psychrophilum. Fish & shellfish
immunology. 2019;85:44-51.
11. Lyons NA, Lyoo YS, King DP, Paton DJ. Challenges of
generating and maintaining protective vaccine-induced
immune responses for foot-and-mouth disease virus in
pigs. Frontiers in veterinary science. 2016;3:102.
12. Kallel H, Jouini A, Majoul S, Rourou SJJob. Evaluation
of various serum and animal protein free media for the
production of a veterinary rabies vaccine in BHK-21
cells. 2002;95(3):195-204.
13. OIE PBJP, France. NB: Version adapted by the World
Assembly of Delegates of the Office International des
epizooties. 2009.
14.Rweyemamu MM, Booth JC, Head M, Pay TWJE,
Infection. Microneutralization tests for serological
typing and subtyping of foot-and-mouth disease virus
strains. 1978;81(1):107-23.
15. Kärber G. Beitrag zur kollektiven Behandlung
pharmakologischer Reihenversuche. NaunynSchmiedebergs Archiv für experimentelle pathologie
und pharmakologie. 1931;162:480-3.
16.Bazid A-HI, El-Alfy HA, El-Didamony G, Elfeil WK,
El-Sayed MM, Fawzy M. Adjuvant effect of saponin in
an oil-based monovalent (serotype O) foot-and-mouth
disease virus vaccine on the antibody response in guinea
pigs and cattle. Archives of Virology. 2021;166:1977-84.
17.Ibrahim EE-S, Gamal WM, Hassan AI, Mahdy SE-D,
Hegazy AZ, Abdel-Atty MM. Comparative study on the
immunopotentiator effect of ISA 201, ISA 61, ISA 50,
ISA 206 used in trivalent foot and mouth disease
vaccine. Veterinary world. 2015;8(10):1189.
18. Pay T, Hingley P. A potency test method for foot and
mouth disease vaccine based on the serum neutralizing
antibody response produced in cattle. Vaccine.
1992;10(10):707-13.
19. Lu Z, Yu S, Wang W, Chen W, Wang X, Wu K, et al.
Development of Foot-and-Mouth Disease Vaccines in
Taghizadeh M et al / Archives of Razi Institute, Vol. 78, No. 6 (2023) 1843-1851 1851
Recent Years. 2022;10(11):1817.
20.Jiang H, Wang Q, Li L, Zeng Q, Li H, Gong T, et al.
Turning the old adjuvant from gel to nanoparticles to
amplify CD8+ T cell responses. 2018;5(1):1700426.
21. Marciani DJJTiPS. Elucidating the mechanisms of
action of saponin-derived adjuvants. 2018;39(6):573-85.
22. Grubman M, Baxt BJARS. Foot-and-Mouth Disease,
clinical microbiology reviews. 17 (2). 465–493. 2004.
23. Khorasani A, Madadgar O, Soleimanjahi H, Keyvanfar
H, Mahravani HJIjovr. Evaluation of the efficacy of a
new oil-based adjuvant ISA 61 VG FMD vaccine as a
potential vaccine for cattle. 2016;17(1):8.
24.Bazid A-H, Amer HM, Nayel M, Attia M, Maklad N,
Wasfy M, et al. Assessment of the potency and
effectiveness of a heptavalent oil-adjuvanted (ISA 206)
foot-and-mouth disease vaccine in Egypt. Archives of
Virology. 2023;168(2):1-8.